.
Cervical cancer is highly preventable when detected early.
Yet current screening creates barriers with:
-Invasive testing
– Lab dependent delayed results
-Incomplete signals
-Multi-step pathway
Each step increases the risk that patients miss the early detection needed before cancer progresses.
Introducing Uricerve™
A new category of rapid, non-invasive detection that meets women where they are.
The future of early detection
Expands access, globally.
ScreenHER’s proprietary technology is designed to offer a rapid, non-invasive point-of-care diagnostic to identify precancer and cancer signals in minutes, enabling same-visit care decisions.
results in minutes. not weeks.
Advancing toward clinical and commercial readiness
We are on a Mission to expand access to early cancer detection, deliver faster answers, and enable better care decisions worldwide.
Stay informed
Enter your email to receive updates on ScreenHER.
The Latest Insights
